Physician profile
Laurie A Orme
NPI 1114925302
$4,780.70
in general payments reported to CMS, 2019-2025
35 companies · $229 in 2025
The $229 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,255 · 2020: $1,092 · 2021: $1,127 · 2022: $361 · 2023: $340 · 2024: $376 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $727.01 | 2019-2025 | |
| Glaxosmithkline, LLC. | $674.07 | 2019-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $537.12 | 2019-2024 | Airsupra |
| Novo Nordisk INC | $439.44 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $431.09 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $397.28 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $306.03 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $190.43 | 2019-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Abbvie INC. | $147.65 | 2021-2024 | |
| Shire North American Group INC | $145.50 | 2019 | |
| Sumitomo Pharma America, INC. | $112.26 | 2023-2024 | Gemtesa |
| Sanofi-Aventis U.S. LLC | $89.08 | 2019-2025 | |
| Exact Sciences Corporation | $75.63 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $50.24 | 2020-2024 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $44.82 | 2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $43.22 | 2020 | |
| Nestle Healthcare Nutrition INC. | $32.43 | 2021 | |
| Abbott Laboratories | $29.90 | 2021-2022 | |
| Astellas Pharma US INC | $28.76 | 2019-2021 | |
| Sanofi Pasteur INC. | $25.93 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $25.33 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $24.40 | 2022 | |
| Alexion Pharmaceuticals, INC. | $23.94 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $19.80 | 2021 | |
| Genentech USA, INC. | $17.49 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $16.78 | 2025 | Evkeeza |
| Novartis Pharmaceuticals Corporation | $16.62 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.30 | 2019 | |
| Amarin Pharma, INC. | $14.57 | 2019 | |
| Gilead Sciences, INC. | $14.22 | 2021 | |
| Dexcom, INC. | $13.75 | 2022 | |
| Vyera Pharmaceuticals, LLC | $13.67 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.64 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.99 | 2019 | |
| Eisai INC. | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurie Orme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.